Heron Therapeutics Shares Are Trading Lower. The FDA Acknowledged the Receipt of the Company's Prior Approval Supplement Application for ZYNRELEF.
Heron Therapeutics Shares Are Trading Lower. The FDA Acknowledged the Receipt of the Company's Prior Approval Supplement Application for ZYNRELEF.
Heron Therapeutics的股票正在交易下跌。FDA確認收到了該公司的ZYNRELEF之前批准補充申請。
Heron Therapeutics Shares Are Trading Lower. The FDA Acknowledged the Receipt of the Company's Prior Approval Supplement Application for ZYNRELEF.
Heron Therapeutics的股票正在交易下跌。FDA確認收到了該公司的ZYNRELEF之前批准補充申請。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。